Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125381101 | 12538110 | 1 | I | 20151213 | 20160629 | 20160707 | 20160707 | PER | US-CELGENEUS-USA-2016067348 | CELGENE | 76.00 | YR | F | Y | 47.30000 | KG | 20160707 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125381101 | 12538110 | 1 | PS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 6110443 | 21660 | 125 | MG/M**2 | INJECTION FOR INFUSION | |||||
| 125381101 | 12538110 | 2 | SS | ABRAXANE | PACLITAXEL | 1 | Intravenous drip | Y | U | 6110443 | 21660 | 100 | MG/M**2 | INJECTION FOR INFUSION | |||||
| 125381101 | 12538110 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 67AB5001A | 55974 | 1000 | MG/M**2 | INJECTION FOR INFUSION | |||||
| 125381101 | 12538110 | 4 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous drip | Y | U | 67AB5001A | 55974 | 800 | MG/M**2 | INJECTION FOR INFUSION | |||||
| 125381101 | 12538110 | 5 | C | Hydromorphone | HYDROMORPHONE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125381101 | 12538110 | 6 | C | LORATADINE. | LORATADINE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125381101 | 12538110 | 7 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125381101 | 12538110 | 8 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125381101 | 12538110 | 9 | C | LOVENOX | ENOXAPARIN SODIUM | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 125381101 | 12538110 | 10 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125381101 | 12538110 | 1 | Pancreatic carcinoma |
| 125381101 | 12538110 | 3 | Pancreatic carcinoma |
| 125381101 | 12538110 | 5 | Product used for unknown indication |
| 125381101 | 12538110 | 6 | Product used for unknown indication |
| 125381101 | 12538110 | 7 | Product used for unknown indication |
| 125381101 | 12538110 | 8 | Product used for unknown indication |
| 125381101 | 12538110 | 9 | Product used for unknown indication |
| 125381101 | 12538110 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125381101 | 12538110 | OT |
| 125381101 | 12538110 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125381101 | 12538110 | Anaemia | |
| 125381101 | 12538110 | Neutropenia | |
| 125381101 | 12538110 | Sepsis | |
| 125381101 | 12538110 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125381101 | 12538110 | 1 | 20151020 | 20151103 | 0 | |
| 125381101 | 12538110 | 2 | 20151124 | 20151208 | 0 | |
| 125381101 | 12538110 | 3 | 20151020 | 20151103 | 0 | |
| 125381101 | 12538110 | 4 | 20151124 | 20151208 | 0 |